CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM

被引:1
|
作者
Aubin, Laure [1 ,2 ,3 ]
Vilas Boas, Ruben [4 ]
Daltro De Oliveira, Rafael [5 ]
Le Brun, Valoris [6 ]
Divoux, Marion [7 ,8 ]
Rey, Jerome [9 ]
Mansier, Olivier [10 ,11 ]
Ianotto, Jean-Christophe [12 ]
Pastoret, Cedric [3 ]
Desmares, Anne [3 ]
Murati, Anne [13 ,14 ]
de Mas, Veronique [15 ]
Tavitian, Suzanne [16 ]
Girodon, Francois [4 ]
Soret Dulphy, Juliette [5 ]
Maslah, Nabih [17 ]
Goncalves Monteiro, Valerie [18 ]
Boyer, Francoise [19 ]
Orvain, Corentin [19 ]
Ranta, Dana [7 ]
Cayssials, Emilie [20 ]
Le Clech, Lenaig [21 ]
Nicol, Christophe [22 ]
Rottier, Camille [23 ]
Botin Lopez, Teresa [24 ]
Castel, Brice [25 ]
Rispal, Patrick [26 ]
Beziat, Guillaume [27 ]
Bescond, Charles [28 ]
Laribi, Kamel [29 ]
Benajiba, Lina [5 ]
Ugo, Valerie [1 ]
Lippert, Eric [6 ,30 ]
Cottin, Laurane [1 ,31 ]
Luque Paz, Damien [1 ,31 ]
机构
[1] Univ Angers, Nantes Univ, SFR ICAT, CRCI2NA,CHU Angers,Inserm,CNRS, F-49000 Angers, France
[2] CH St Malo, Lab Hematol, St Malo, France
[3] CHU Rennes, Lab Hematol, Rennes, France
[4] CHU Dijon, Lab Hematol, Dijon, France
[5] Univ Paris, Hop St Louis, APHP, CNRS,INSERM,U944,UMR7212, Paris, France
[6] CHRU Brest, Lab Hematol, Brest, France
[7] CHU Nancy, Hematol Clin, Nancy, France
[8] CHU Nancy, Lab Hematol, Nancy, France
[9] Inst Paoli Calmettes, Ctr Rech Cancerol Marseille CRCM, Dept Hematol, Marseille, France
[10] CHU Bordeaux, Lab Hematol, Bordeaux, France
[11] Univ Bordeaux, Inserm, U1034, Bordeaux, France
[12] CHU Brest, Serv Hematol Clin, Brest, France
[13] Inst Paoli Calmettes, Ctr Rech Cancerol Marseille CRCM, Dept Biopathol, Inserm, Marseille, France
[14] Inst Paoli Calmettes, Dept Oncol Predict, Inserm, Marseille, France
[15] CHU Toulouse, Inst Univ Canc Toulouse Oncopole, Lab Hematol, Toulouse, France
[16] CHU Toulouse, Inst Univ Canc Toulouse Oncopole, Serv Hematol, Toulouse, France
[17] Univ Paris Cite, Hop St Louis, Lab Biol Cellulaire, APHP, Paris, France
[18] CHU Reims, Lab Hematol, Reims, France
[19] CHU Angers, Serv Malad Sang, Angers, France
[20] CHU Poitiers, Serv Oncol Hematol & Therapie Cellulaire, Poitiers, France
[21] CH Cornouaille, Hematol Clin, Quimper, France
[22] CH Pays Morlaix, Hematol Clin, Morlaix, France
[23] CHU Amiens, Lab Hematol, Amiens, France
[24] CH Castres, Hematol Clin, Castres, France
[25] CH Bigorre, Serv Med Interne, Tarbes, France
[26] CH Agen, Serv Med Interne, Agen, France
[27] CH Albi, Hematol Clin, Albi, France
[28] CH Cholet, Hematol Clin, Cholet, France
[29] CH Le Mans, Hematol Clin, Le Mans, France
[30] Brest Univ, INSERM, U1078, Brest, France
[31] CHU ANGERS, Inst Biol Sante, Lab Hematol, 4 Rue Larrey, F-49933 Angers 9, France
关键词
D O I
10.1002/ajh.27265
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1001 / 1004
页数:4
相关论文
共 13 条
  • [1] PATIENTS WITH TRIPLE NEGATIVE OR CALR-MUTATED ESSENTIAL THROMBOCYTHEMIA HAVE A LOW RISK OF THROMBOSIS
    Bertozzi, I.
    Peroni, E.
    Coltro, G.
    Bogoni, G.
    Santarossa, C.
    Fabris, F.
    Randi, M. L.
    HAEMATOLOGICA, 2015, 100 : 109 - 109
  • [2] A Study of the Role of Antiplatelet Therapy in the Prevention of Thrombosis in Patients with Calr-Mutated Low Risk Essential Thrombocythemia
    Alvarez-Larran, Alberto
    Guglielmelli, Paola
    Arellano-Rodrigo, Eduardo
    Griesshammer, Martin
    Paoli, Chiara
    Kerguelen, Ana
    Ferrer-Marin, Francisca
    Carlos Hernandez-Boluda, Juan
    Andreasson, Bjorn
    Schwarz, Jiri
    Garcia-Gutierrez, Valentin
    Ayala, Rosa M.
    Barba, Pere
    Teresa Gomez-Casares, Maria
    Skoda, Radek C.
    Burgaletar, Carmen
    Slot, Stefanie
    Samuelsson, Jan
    Samah, Alimam
    Beauverd, Yan
    Harrison, Claire N.
    Cervantes, Francisco
    Vannucchi, Alessandro M.
    Besses, Carlos
    BLOOD, 2015, 126 (23)
  • [3] Clinical effect of CALR allele burden in patients with essential thrombocythemia
    Bertozzi, Irene
    Biagetti, Giacomo
    Vezzaro, Tommaso
    Barzon, Isabella
    Carraro, Marco
    Fabris, Fabrizio
    Randi, Maria Luigia
    ANNALS OF HEMATOLOGY, 2022, 101 (06) : 1345 - 1346
  • [4] DYNAMICS OF CALR MUTANT ALLELE BURDEN IN ESSENTIAL THROMBOCYTHEMIA PATIENTS
    Bellosillo, B.
    Longaron, R.
    Pairet, S.
    Alvarez-Larran, A.
    Martinez-Aviles, L.
    Camacho, L.
    Fernandez-Rodriguez, C.
    Angona, A.
    Ancochea, A.
    Serrano, S.
    Besses, C.
    HAEMATOLOGICA, 2014, 99 : 131 - 131
  • [5] Clinical effect of CALR allele burden in patients with essential thrombocythemia
    Irene Bertozzi
    Giacomo Biagetti
    Tommaso Vezzaro
    Isabella Barzon
    Marco Carraro
    Fabrizio Fabris
    Maria Luigia Randi
    Annals of Hematology, 2022, 101 : 1345 - 1346
  • [6] Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature
    Alimam, Samah
    Villiers, William
    Dillon, Richard
    Simpson, Michael
    Runglall, Manohursingh
    Smith, Alexander
    Chatzikyriakou, Prodromos
    Lavender, Paul
    Kanda, Anju
    Mills, Ken
    Paricio, Beatriz Bellosillo
    Kaufman-Cook, James
    Ord, Sophie
    Kordasti, Shahram
    Radia, Deepti
    Woodley, Claire
    Francis, Yvonne
    Mufti, Ghulam
    McLornan, Donal P.
    Harrison, Claire N.
    BLOOD ADVANCES, 2021, 5 (04) : 1059 - 1068
  • [7] Monitoring of Calr Allele Burden in Patients with Essential Thrombocythemia Treated with Imetelstat, a Telomerase Inhibitor, Reveals Rapid and Substantial Molecular Responses
    Baerlocher, Gabriela M.
    Haubitz, Monika
    Ottmann, Oliver G.
    Odenike, Olatoyosi
    Roeth, Alexander
    McDevitt, Michael A.
    Shih, Ted
    Burington, Bart
    Morfeld, Dianne
    Batra, Neeru
    Snyder, David
    Leibundgut, Elisabeth Oppliger
    BLOOD, 2014, 124 (21)
  • [8] Aspirin therapy is associated with a lower risk of pregnancy loss in both JAK2- and CALR-mutated essential thrombocythemia-A Mayo Clinic study of 200 pregnancies
    Gangat, Naseema
    Singh, Amritpal
    Ilyas, Rimal
    Loscocco, Giuseppe Gaetano
    Elliott, Michelle
    Begna, Kebede
    Pardanani, Animesh
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (10) : 1862 - 1869
  • [9] Single-Cell Multi-Omics Reveals That Pegylated Interferon-Alfa Treatment Differentially Redirects Mutated and Wildtype Hematopoietic Cell Differentiation Trajectories in CALR-mutated Essential Thrombocythemia (ET) Patients
    Rosenberg, Shira
    Kubas-Meyer, Andrea
    Parghi, Neelang
    Omans, Nathaniel D.
    Dusai, Neville
    Chamely, Paulina
    Mimitou, Eleni
    Dueck, Amylou C.
    Kosiorek, Heidi E.
    Weinberg, Rona Singer
    Smibert, Peter
    Chaligne, Ronan
    Landau, Dan A.
    Hoffmann, Ronald
    Nam, Anna S.
    BLOOD, 2021, 138
  • [10] Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature (vol 5, pg 1059, 2021)
    Alimam, S.
    Villiers, W.
    Dillon, R.
    BLOOD ADVANCES, 2021, 5 (12) : 2575 - 2575